Teladoc Health (NYSE:TDOC) Insider Sells $43,315.51 in Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Fernando Rodrigues sold 5,677 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $43,315.51. Following the completion of the sale, the insider owned 9,572 shares in the company, valued at $73,034.36. The trade was a 37.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $7.05 on Friday. The firm’s 50 day moving average is $6.20 and its two-hundred day moving average is $6.22. Teladoc Health, Inc. has a 52 week low of $4.40 and a 52 week high of $9.77. The firm has a market capitalization of $1.27 billion, a P/E ratio of -7.26 and a beta of 2.14. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, April 29th. The health services provider reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The firm had revenue of $613.85 million during the quarter, compared to analyst estimates of $611.04 million. During the same quarter in the previous year, the business posted ($0.53) EPS. Teladoc Health’s revenue for the quarter was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Analysts anticipate that Teladoc Health, Inc. will post -0.92 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently commented on TDOC. Weiss Ratings upgraded shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 22nd. Piper Sandler reiterated an “overweight” rating and set a $9.00 price objective (down from $12.00) on shares of Teladoc Health in a research note on Thursday, February 26th. Oppenheimer lowered their price objective on shares of Teladoc Health from $12.00 to $7.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 3rd. Bank of America upgraded shares of Teladoc Health from a “neutral” rating to a “buy” rating and set a $7.00 price objective on the stock in a research note on Thursday, February 26th. Finally, Leerink Partners lowered their price objective on shares of Teladoc Health from $8.50 to $5.50 and set a “market perform” rating on the stock in a research note on Thursday, February 26th. Five equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $7.43.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Essential Partners LLC acquired a new position in Teladoc Health in the first quarter worth approximately $113,000. Janus Henderson Group PLC grew its position in Teladoc Health by 7.7% in the first quarter. Janus Henderson Group PLC now owns 262,215 shares of the health services provider’s stock worth $1,429,000 after buying an additional 18,679 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in Teladoc Health by 694.5% in the first quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock worth $31,000 after buying an additional 4,945 shares during the last quarter. California State Teachers Retirement System grew its position in Teladoc Health by 61.2% in the first quarter. California State Teachers Retirement System now owns 274,441 shares of the health services provider’s stock worth $1,496,000 after buying an additional 104,160 shares during the last quarter. Finally, Quantinno Capital Management LP grew its position in Teladoc Health by 128.0% in the first quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock worth $14,287,000 after buying an additional 1,471,631 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.